Clinical trials: Vision Screening
Primary Parkinsonism, Secondary Vascular Parkinson Disease
Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms
Based on a prospectively collected data analysis, a new tool, namely CoMDA (Cognition in Movement Disorders Assessment) is developed by merging each item of Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment…
- Conditions
- Primary Parkinsonism, Secondary Vascular Parkinson Disease, Multiple System Atrophy, Supranuclear Palsy, Progressive
- Trial name
- CoMDA-ML-P (NCT04858893)
- Testing
- CoMDA associated with Neural Net 91 classificator
- Where
- Italy
- Volunteers
- 562 people, healthy volunteers welcome
- Sponsor
- Ospedale Generale Di Zona Moriggia-Pelascini
Glaucoma
Glaucoma Screening
The primary objective of this study is to evaluate the diagnostic accuracy of the TEMPO (iMOvifa) visual field perimeter screening test by measuring the sensitivity in a population of eyes with glaucoma and the specificity in a…
- Trial name
- NCT06186388
- Testing
- TEMPO iMOvifa
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Cape Fear Eye Institute
Screening
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Incentives
This is a randomized trial to assess whether offering a financial incentive will improve the response rate to a telephone survey.
- Trial name
- GSearch-SRI (NCT07755748)
- Testing
- $5 gift card, $100 monthly drawing
- Where
- 2 sites in United States
- Volunteers
- 2,000 people
- Sponsor
- University of California, San Francisco
Advanced Heart Failure, CRT and/or ICD
Screening for Advanced Heart Failure Treatment (SEE-HF)
Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with…
- Trial name
- SEE-HF (NCT01626404)
- Where
- 7 sites in Denmark, France and 4 more
- Volunteers
- 99 people
- Sponsor
- Abbott Medical Devices
Visual Deficiency, Congenital Blindness
VISIODOL: Validation of the VISIODOL® Scale
The aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.
- Conditions
- Visual Deficiency, Congenital Blindness, Acquired Blindness
- Trial name
- VISIODOL (NCT03968991)
- Testing
- VISIODOL® (Diagnostic tool)
- Where
- France
- Volunteers
- 37 people, healthy volunteers welcome
- Sponsor
- University Hospital, Clermont-Ferrand
Glaucoma, Ocular Hypertension
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
The goal of this clinical trial is to learn if implementation of an eye screening program at Federally Qualified Health Center (FQHC) clinics provides results that participants may have glaucoma, and/or other eye conditions…
- Trial name
- AI-RONA (NCT06629649)
- Testing
- Glaucoma screening using an AI-algorithm and screening for diabetic retinopathy, cataract, and visual acuity impairment.
- Where
- United States
- Volunteers
- 1,800 people
- Sponsor
- University of Alabama at Birmingham
Glaucoma, Diagnostic Self-evaluation
Development and Evaluation of a Self-administered/Assisted Visual Field Screening Tool for Glaucoma
This project aims to evaluate a self-administered screening test for glaucoma, the second largest cause of blindness in the western world.
- Trial name
- NCT02162043
- Where
- United Kingdom
- Volunteers
- 168 people, healthy volunteers welcome
- Sponsor
- University of Manchester
Glaucoma, Diabetic Retinopathy
Glaucoma Algorithm Validation Study in African Population - the MAGIC Study
Artificial Intelligence (AI) algorithms require validation in a variety of populations to ensure widespread clinical applicability.
- Trial name
- MAGIC (NCT06552247)
- Testing
- Fundus Picture AI testing
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Centro Hospitalar Universitário Lisboa Norte
Adenoma Detection Rate
A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®)
The aim of this study is to evaluate the effect of ENDOCUFF VISION® (caps with soft, about 1 cm long lateral feet of rubber ("Endocuff") to flatten the colon folds) on ADR in a real-life setting (general practices) and in a…
- Trial name
- Endocuff (NCT03442738)
- Testing
- Endocuff group
- Where
- 9 sites in Germany
- Volunteers
- 1,382 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
Eye Diseases, Visual Impairment
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic…
- Conditions
- Eye Diseases, Visual Impairment, Glaucoma
- Trial name
- SIGHT (NCT06934577)
- Testing
- Standard optometric examination, Technology enhanced eye disease detection protocol
- Where
- United States
- Volunteers
- 900 people
- Sponsor
- University of Michigan
Visual Disorders
Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory
Visual disorders are often overlooked in the treatment of cognitive disorders of the elderly. Yet the visual deficit impacts the quality of life, the evolution of the autonomy and psycho-behavioral disorders in cognitive…
- Trial name
- EVAM (NCT02571647)
- Testing
- Non interventional study
- Where
- France
- Volunteers
- 300 people
- Sponsor
- Nantes University Hospital
Age Related Macular Degeneration
Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes
Hypothesis: The use of teleophthalmology for patient screening will result in more rapid patient access for treatment. The use of teleophthalmology to monitor patients with wet AMD post-treatment will result in maintenance of…
- Trial name
- NCT01581606
- Where
- Canada
- Volunteers
- 169 people
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Glaucoma
Barcelona Esquerra Glaucoma Artificial Intelligence-based Screening Program (BEGAS)
Two primary care-based screening systems will be tested to identify subjects with referrable glaucoma to hospital care. Subjects between 45 to 64 years old living in the metropolitan area of Barcelona will be invited to…
- Trial name
- BEGAS (NCT06353542)
- Testing
- Software analysis, Ophthalmologist examination
- Where
- Spain
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Hospital Clinic of Barcelona